Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry

Abstract

Continuation or short-term interruption of NOAC is safe strategies for most invasive procedures. Patients at cardiovascular risk undergoing major procedures may benefit from heparin bridging, but bleeding risks need to be considered.